Study title: Serial blood lactate measurements predict early outcome after neonatal repair or palliation for complex congenital heart disease - Charpie JR et al. - 2000 (J Thorac Cardiovasc Surg 2000, 120, 73-80)Serial blood lactate measurements predict early outcome after neonatal repair or palliation for complex congenital heart disease - Charpie JR et al. - 2000 (J Thorac Cardiovasc Surg 2000, 120, 73-80)
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Cardiovascular Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: MILRINONE | |||||
| ATC code: C01CE02 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | Y | - | - | - | |